Based upon these previous findings on diabetes and coronary heart disease risk, two conditions strongly linked to NAFLD [9,11], we examined the association of apoA1 in HDL that contained or lacked apoC3 with liver fat content and NAFLD in the Multi-Ethnic Study of Atherosclerosis (MESA). This evidence concerns the gene APOA1 and metabolic dysfunction-associated steatotic liver disease.